TeamDrive
RUS

Doctor Ryadom

www.drclinics.ru

Doctor Ryadom is a dynamically developed network of private clinics which was created in Moscow in 2014 by Team Drive and a group of private investors within public-private partnership with Moscow City Government. 

The first clinic started its work in April 2014 in a new, densely populous district in South-East of Moscow. 

In less than a year Doctor Ryadom opened in such areas of Moscow 10 modern, well-equipped, multidimensional clinics for adults and children. All clinics offer free reception of public using mandatory health insurance policy when patients with voluntary health insurance and on a fee basis are also serviced.  A wide range of modern technologies are fixed in the network of clinics Doctor Ryadom which are based on personalized medicine.

The project is actively developing: the company is planning to improve and expand the network of clinics and create clinical and diagnostic centers.

You can read all the details on Doctor Ruyadom website.

Media Center

  • 24 May 2018

    State Duma adopted a bill to simplify registration of drugs

    It will be possible to register drugs that have the same international nonproprietary names, but different trade names, and being manufactured at the same site. The corresponding government bill No. 327290-7 on amendments to the Federal Law “On Circulation of Medicines” was adopted by the State Duma in the third reading.

  • 23 May 2018

    Today’s realities in the development of local and contract manufacturing

    The representatives of pharmaceutical companies met at the forum of the Adam Smith Institute where they shared their views on the development of local and contract manufacturing. Victor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers, said that Russian manufacturers continue to consider the quality of their products as the most important issue.

  • 23 May 2018

    Russian Ministry included the Kirov region biotech cluster in its register

    The Ministry of Industry and Trade of Russia confirmed that the industrial biotechnology cluster of the Kirov region and its specialized organization “The Association of Industrial Biotechnology Cluster” comply with the requirements approved by the Decree of the Russian Government No. 779, dated July 31, 2016.

  • 22 May 2018

    Russian pharmaceutical market: stability in unstable environment

    According to DSM Group, in 2017, the Russian market was worth 1629 billion rubles, which 8% higher than in 2016. For the first time in three years, the market grew in dollar- and euro-denominated terms. In physical terms, the market growth is similar to the dynamics in value terms. Therefore, the factor of higher prices played virtually no role in expanding the market volume. In 2017, the main driver was the increase in the actual consumption of medicinal products, i.e., the growth in terms of sold packages.

Read more